Verastem (VSTM) Stock: Buy, Sell, or Hold?
VSTM - Verastem, Inc.
$10.06
0.85 (9.23%)
β²
5d:
+8.99%
30d:
+22.98%
90d:
+66.28%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 03, 2026
10d
Get Alerted When VSTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR BETTER ENTRY: VSTM is 14.7% above its trading range ($8.77). While momentum could continue, risk/reward favors waiting for a pullback.
βΈοΈ WAIT FOR BETTER ENTRY: VSTM is 14.7% above its trading range ($8.77). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: VSTM is currently trading at $10.06, which is considered extended relative to its 30-day fair value range of $7.48 to $8.77.
Technical Outlook: Technically, VSTM is in a strong uptrend. The price is approaching resistance at $10.11. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 9.2% recently.
Market Sentiment: VSTM scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.22 (+71.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VSTM is in a strong uptrend. The price is approaching resistance at $10.11. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 9.2% recently.
Market Sentiment: VSTM scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.22 (+71.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$7.48 -
$8.77
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
21.1%
Protect Your Profits
Holding VSTM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+14.7% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.2%)
- BULLISH: Trading 71.2% below Wall St target ($17.22)
- WARNING: Composite score 44/100 in the bottom quintile β this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$7.48 -
$8.77
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$6.70
Resistance Level
$10.11
Current Trend
Strong Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.25
Wall Street Target
$17.22
(+71.2%)
Revenue Growth (YoY)
1775.4%
Profit Margin
-231.6%
Share & Embed Analysis
Last updated: October 23, 2026 5:14 AM ET
Data refreshes hourly during market hours. Next update: 6:14 AM
Data refreshes hourly during market hours. Next update: 6:14 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VSTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$295 | 62 BUY |
|
REGN
Regeneron Pharmaceutical⦠|
BUY
28 analysts |
$864 | 44 HOLD |
|
PRAX
Praxis Precision Medicin⦠|
STRONG BUY
20 analysts |
$650 | 61 BUY |
|
DYN
Dyne TherapeuticsΒ Inc |
STRONG BUY
17 analysts |
$36 | 57 HOLD |
|
ACAD
ACADIA Pharmaceuticals I⦠|
STRONG BUY
20 analysts |
$31 | 66 BUY |
Advanced VSTM Option Strategies
Professional options setups generated by AI based on today's VSTM price and gamma walls.